← Eichor
Study identifier: NCT06599931 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Cerebello-motor Neuromodulation After Stroke. CERSTIM.

Condition: Stroke · Healthy  ·  Sponsor: Institut National de la Santé Et de la Recherche Médicale, France

PhaseNA
Planned participants45
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The CERSTIM study is a physiopatholgical study investigating transcranial alternating current stimulation in stroke patients in the cerebello-motor loop. The design is a cross over design testing two frequencies in the gamma band and one placebo. We will use behavioural data, functional MRI, and Electroencephalography to disentangle the effect of tACS and its frequency. Healthy participants will be also recruited.

This description comes directly from the study's public registry record.

Talk to the study team

Charlotte ROSSO, MD PhD  ·  +33142162103  ·  charlotte.rosso@aphp.fr

Isabelle LOUBINOUX, PhD  ·  +33562746183  ·  isabelle.loubinoux@inserm.fr

Always discuss trial participation with your own doctor first.

Locations (2)

ICM_ Institut du Cerveau et de la Moelle épinière, Hôpital Pitié, 47 Bd de l'HôpitalParis, FranceRecruiting
ToNIC - Toulouse neuro Imaging center (Inserm)Pavillon BaudotToulouse, FranceNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06599931